Transaction · 0001022079-26-000028

Davis J. E.

Davis J. E., CEO, PRES, reported a transaction classified as grant at QUEST DIAGNOSTICS INC involving 51652.000000 shares for an estimated $10581428.72. Reported holdings after the transaction were 168837.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACEO, PRES
DGXQUEST DIAGNOSTICS INC
Filing timeMar 06
Trade dateMar 04, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$199.21
Pre-filing
1mo ago -7.1%1w ago +4.3%1d ago +4.6%
Returns since
7d +0.2%30d -0.6%90d -1.6%180d +22.8%1y +22.8%

DGX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
DGX since 2026-03-06Filed 182 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001022079-26-000028
Common Stock
Transaction date
Mar 04, 2026
Filed Mar 06, 2026, 12:00 AM · 2d delay
Shares
51.6k sh
$20.4k per share
Estimated value
$1.05B
Computed from shares × price
Holdings after
168k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Holdings Increase
-12score
Filing-only score

-12

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO and President

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).

  2. F2

    Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.

Original filing · 0001022079-26-000028
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

DGX